Peeking Into a Cool Future: Genome Editing to Delete PCSK9 and Control Hypercholesterolemia in a Single Shot

Circulation Research - United States
doi 10.1161/circresaha.114.304575
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

The Future of Genome Editing

Cell
BiochemistryGeneticsMolecular Biology
2018English

Permanent Alteration of PCSK9 With in Vivo CRISPR-Cas9 Genome Editing

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2014English

Genome Editing and the Future of Farming Meeting Report

Transgenic Research
GeneticsCrop ScienceAnimal ScienceZoologyBiotechnologyAgronomy
2017English

PCSK9 as Predictor for Recurrent Cardiovascular Disease in Familial Hypercholesterolemia

European Journal of Preventive Cardiology
EpidemiologyCardiovascular MedicineCardiology
2019English

Efficient CRISPR/Cas9-Mediated Genome Editing Using a Chimeric Single-Guide RNA Molecule

Frontiers in Plant Science
Plant Science
2017English

A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9

Annual Review of Chemical and Biomolecular Engineering
Renewable EnergyChemistrythe EnvironmentChemical EngineeringSustainability
2017English

Bergamot Polyphenols: A Phytotherapeutic Approach to Hyperlipidemia and Hypercholesterolemia Control

Pharmacologia
2015English

Gingival Ischemia and Petechiae in a Patient Medicated With PCSK9 Inhibitor for Hypercholesterolemia. An Adverse Drug Event?

Clinical advances in periodontics
Periodontics
2018English

The Control of Paramyxovirus Genome Hexamer Length and mRNA Editing

RNA
Molecular Biology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy